UBS Group’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
|
|||||
|
2025
Q1 | $585K | Buy |
|
|||||
|
2024
Q4 | $188K | Buy |
|
|||||
|
2024
Q3 | $93.1K | Buy |
|
|||||
|
2024
Q2 | $53.7K | Sell |
|
|||||
|
2024
Q1 | $145K | Buy |
|
|||||
|
2023
Q4 | $42K | Buy |
|
|||||
|
2023
Q3 | $49.2K | Sell |
|
|||||
|
2023
Q2 | $57.5K | Buy |
|
|||||
|
2023
Q1 | $14K | Buy |
|
|||||
|
2022
Q4 | $5.97K | Sell |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $13K | Buy |
|
|||||
|
2022
Q1 | $4K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $7K | Buy |
|
|||||
|
2021
Q2 | $5K | Sell |
|
|||||
|
2021
Q1 | $6K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $7K | Sell |
|
|||||
|
2019
Q2 | $14K | Buy |
|